₹2.90
(Market cap
₹2,761 Cr
Recently Viewed
Clear AllMarket cap
₹2,761 Cr
Revenue (TTM)
₹2,227 Cr
P/E Ratio
23.8
P/B Ratio
1.6
Div. Yield
0.9 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹116 Cr
ROE
6.1 %
ROCE
8.9 %
Industry P/E
34.7
EV/EBITDA
10.4
Debt to Equity
0.1
Book Value
₹60.4
EPS
₹4.2
Face value
2
Shares outstanding
293,527,510
CFO
₹2,028.23 Cr
EBITDA
₹2,765.32 Cr
Net Profit
₹1,577.20 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
IOL Chemicals
| 14.4 | 26.6 | 33.6 | 39.1 | 6.5 | -4.6 | 18.7 |
|
BSE Healthcare
| 0.1 | 2.8 | 5.2 | 3.6 | 24.0 | 13.2 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
IOL Chemicals
| 0.0 | -13.9 | 24.1 | -22.8 | -35.7 | 332.3 | 5.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
IOL Chemicals
|
94.1 | 2,760.6 | 2,227.4 | 115.9 | 7.2 | 7.2 | 23.8 | 1.6 |
| 1,056.9 | 12,975.7 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.9 | 4.1 | |
| 416.9 | 7,236.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 24.6 | 5.6 | |
| 1,052.2 | 11,007.7 | 1,158.7 | 309.6 | 31.9 | 17.3 | 35.2 | 5.8 | |
| 1,597.9 | 30,250.9 | 8,850.1 | 894.8 | 15.2 | 19.8 | 34.8 | 6.1 | |
| 328.0 | 3,571.3 | 159.3 | 47.8 | 39.0 | 18.6 | 74.7 | 12.9 | |
| 15,067.0 | 19,346.1 | 1,575.1 | 179.1 | 14.9 | 11.4 | 108 | 11.7 | |
| 882.5 | 4,067.9 | 588.5 | 102.9 | 22.1 | 12.7 | 40 | 4.8 | |
| 675.0 | 7,625.2 | 502.0 | 138.7 | -- | 32.8 | 55 | 8.8 | |
| 212.6 | 5,601.4 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.4 |
2 min read•By Jugal Harpalani
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other... APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India. Read more
Incorporated
1986
Chairman
Rajender Mohan Malla
Managing Director
Varinder Gupta
Group
Trident
Headquarters
Barnala, Punjab
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of IOL Chemicals And Pharmaceuticals Ltd is ₹94.13 (NSE) and ₹94.05 (BSE) as of 22-Apr-2026 IST. IOL Chemicals And Pharmaceuticals Ltd has given a return of 6.48% in the last 3 years.
The P/E ratio of IOL Chemicals And Pharmaceuticals Ltd is 23.82 times as on 22-Apr-2026, a 31 discount to its peers’ median range of 34.70 times.
The P/B ratio of IOL Chemicals And Pharmaceuticals Ltd is 1.56 times as on 22-Apr-2026, a 30 discount to its peers’ median range of 2.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
17.78
|
1.06
|
|
2024
|
3.16
|
1.32
|
|
2023
|
11.94
|
1.10
|
|
2022
|
12.39
|
1.49
|
|
2021
|
7.27
|
2.56
|
The 52-week high and low of IOL Chemicals And Pharmaceuticals Ltd are Rs 126.66 and Rs 60.90 as of 22-Apr-2026.
IOL Chemicals And Pharmaceuticals Ltd has a market capitalisation of ₹ 2,761 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in IOL Chemicals And Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.